Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Change In Inventory : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Change In Inventory?

Shenzhenlubris Pharmaceuticals Co's change in inventory for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Shenzhenlubris Pharmaceuticals Co's inventory stayed the same from Dec. 2023 to Mar. 2024 .

Shenzhenlubris Pharmaceuticals Co's change in inventory for the fiscal year that ended in Dec. 2023 was ¥51 Mil. It means Shenzhenlubris Pharmaceuticals Co's inventory declined by ¥51 Mil from Dec. 2022 to Dec. 2023 .

Shenzhenlubris Pharmaceuticals Co's Total Inventories for the quarter that ended in Mar. 2024 was ¥457 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shenzhenlubris Pharmaceuticals Co's Days Inventory for the quarter that ended in Mar. 2024 was 138.89.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shenzhenlubris Pharmaceuticals Co's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.66.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shenzhenlubris Pharmaceuticals Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.43.

Shenzhenlubris Pharmaceuticals Co Change In Inventory Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Change In Inventory Chart

Shenzhenlubris Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

67.55

111.42

-46.53

-114.11

51.23

Shenzhenlubris Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Shenzhenlubris Pharmaceuticals Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shenzhenlubris Pharmaceuticals Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	474.067	/	311.449	*	365 / 4
	=	138.89

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shenzhenlubris Pharmaceuticals Co's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	311.449	/	474.067
	=	0.66

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shenzhenlubris Pharmaceuticals Co's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	474.067	/	1090.969
	=	0.43

Shenzhenlubris Pharmaceuticals Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN

Website

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.

Executives

Yan Jie	Directors, executives
Yang Jian Feng	Secretary, Director
Zhao Song Ping	Executives
Liu Jun	Executives
Li Ai Zhen	Supervisors
Chen Ping	Executives
Ye Cheng Hai	Director
Lu Feng	Executives, directors
Chen Qiong Xing	Supervisors
Li Ying Hui	Supervisors
Pan Ling Man	Independent director
Zhang Zhong Xing	Executives

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines